<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-06-01" modified="2017-03-15" version="133">
<accession>Q9UGI9</accession>
<accession>Q4QQG8</accession>
<accession>Q4V779</accession>
<accession>Q9NRL1</accession>
<name>AAKG3_HUMAN</name>
<protein>
<recommendedName>
<fullName>5'-AMP-activated protein kinase subunit gamma-3</fullName>
<shortName>AMPK gamma3</shortName>
<shortName>AMPK subunit gamma-3</shortName>
</recommendedName>
</protein>
<gene>
<name type="primary">PRKAG3</name>
<name type="synonym">AMPKG3</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2000" name="Biochem. J." volume="346" first="659" last="669">
<title>Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding.</title>
<authorList>
<person name="Cheung P.C.F."/>
<person name="Salt I.P."/>
<person name="Davies S.P."/>
<person name="Hardie D.G."/>
<person name="Carling D."/>
</authorList>
<dbReference type="PubMed" id="10698692"/>
<dbReference type="DOI" id="10.1042/bj3460659"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="Science" volume="288" first="1248" last="1251">
<title>A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle.</title>
<authorList>
<person name="Milan D."/>
<person name="Jeon J.-T."/>
<person name="Looft C."/>
<person name="Amarger V."/>
<person name="Robic A."/>
<person name="Thelander M."/>
<person name="Rogel-Gaillard C."/>
<person name="Paul S."/>
<person name="Iannuccelli N."/>
<person name="Rask L."/>
<person name="Ronne H."/>
<person name="Lundstroem K."/>
<person name="Reinsch N."/>
<person name="Gellin J."/>
<person name="Kalm E."/>
<person name="Le Roy P."/>
<person name="Chardon P."/>
<person name="Andersson L."/>
</authorList>
<dbReference type="PubMed" id="10818001"/>
<dbReference type="DOI" id="10.1126/science.288.5469.1248"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Skeletal muscle</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT ALA-71</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="J. Clin. Invest." volume="113" first="274" last="284">
<title>CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations.</title>
<authorList>
<person name="Scott J.W."/>
<person name="Hawley S.A."/>
<person name="Green K.A."/>
<person name="Anis M."/>
<person name="Stewart G."/>
<person name="Scullion G.A."/>
<person name="Norman D.G."/>
<person name="Hardie D.G."/>
</authorList>
<dbReference type="PubMed" id="14722619"/>
<dbReference type="DOI" id="10.1172/JCI19874"/>
</citation>
<scope>DOMAIN CBS</scope>
<scope>AMP-BINDING</scope>
<scope>ATP-BINDING</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2007" name="EMBO J." volume="26" first="806" last="815">
<title>Regulation of AMP-activated protein kinase by a pseudosubstrate sequence on the gamma subunit.</title>
<authorList>
<person name="Scott J.W."/>
<person name="Ross F.A."/>
<person name="Liu J.K."/>
<person name="Hardie D.G."/>
</authorList>
<dbReference type="PubMed" id="17255938"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601542"/>
</citation>
<scope>DOMAIN AMPK PSEUDOSUBSTRATE</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2007" name="Circ. Res." volume="100" first="328" last="341">
<title>AMP-activated protein kinase in metabolic control and insulin signaling.</title>
<authorList>
<person name="Towler M.C."/>
<person name="Hardie D.G."/>
</authorList>
<dbReference type="PubMed" id="17307971"/>
<dbReference type="DOI" id="10.1161/01.RES.0000256090.42690.05"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2007" name="Nat. Rev. Mol. Cell Biol." volume="8" first="774" last="785">
<title>AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy.</title>
<authorList>
<person name="Hardie D.G."/>
</authorList>
<dbReference type="PubMed" id="17712357"/>
<dbReference type="DOI" id="10.1038/nrm2249"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2011" name="Autophagy" volume="7" first="696" last="706">
<title>Ulk1-mediated phosphorylation of AMPK constitutes a negative regulatory feedback loop.</title>
<authorList>
<person name="Loffler A.S."/>
<person name="Alers S."/>
<person name="Dieterle A.M."/>
<person name="Keppeler H."/>
<person name="Franz-Wachtel M."/>
<person name="Kundu M."/>
<person name="Campbell D.G."/>
<person name="Wesselborg S."/>
<person name="Alessi D.R."/>
<person name="Stork B."/>
</authorList>
<dbReference type="PubMed" id="21460634"/>
<dbReference type="DOI" id="10.4161/auto.7.7.15451"/>
</citation>
<scope>PHOSPHORYLATION BY ULK1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2007" name="PLoS ONE" volume="2" first="E903" last="E903">
<title>Gain-of-function R225W mutation in human AMPKgamma(3) causing increased glycogen and decreased triglyceride in skeletal muscle.</title>
<authorList>
<person name="Costford S.R."/>
<person name="Kavaslar N."/>
<person name="Ahituv N."/>
<person name="Chaudhry S.N."/>
<person name="Schackwitz W.S."/>
<person name="Dent R."/>
<person name="Pennacchio L.A."/>
<person name="McPherson R."/>
<person name="Harper M.E."/>
</authorList>
<dbReference type="PubMed" id="17878938"/>
<dbReference type="DOI" id="10.1371/journal.pone.0000903"/>
</citation>
<scope>VARIANTS ALA-71; GLN-76; GLY-103; VAL-113; VAL-153; PRO-161; SER-171; SER-180; THR-197; GLN-211; GLN-225; TRP-225; ARG-260; THR-269; CYS-307; GLN-340; TRP-340; MET-446; VAL-482 AND ASN-485</scope>
<scope>POLYMORPHISM</scope>
</reference>
<comment type="function">
<text evidence="4">AMP/ATP-binding subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Gamma non-catalytic subunit mediates binding to AMP, ADP and ATP, leading to activate or inhibit AMPK: AMP-binding results in allosteric activation of alpha catalytic subunit (PRKAA1 or PRKAA2) both by inducing phosphorylation and preventing dephosphorylation of catalytic subunits. ADP also stimulates phosphorylation, without stimulating already phosphorylated catalytic subunit. ATP promotes dephosphorylation of catalytic subunit, rendering the AMPK enzyme inactive.</text>
</comment>
<comment type="subunit">
<text evidence="1">AMPK is a heterotrimer of an alpha catalytic subunit (PRKAA1 or PRKAA2), a beta (PRKAB1 or PRKAB2) and a gamma non-catalytic subunits (PRKAG1, PRKAG2 or PRKAG3). Interacts with FNIP1 and FNIP2 (By similarity).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9UGI9-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9UGI9-2</id>
<name>2</name>
<sequence type="described" ref="VSP_015587"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Skeletal muscle, with weak expression in heart and pancreas.</text>
</comment>
<comment type="domain">
<text>The AMPK pseudosubstrate motif resembles the sequence around sites phosphorylated on target proteins of AMPK, except the presence of a non-phosphorylatable residue in place of Ser. In the absence of AMP this pseudosubstrate sequence may bind to the active site groove on the alpha subunit (PRKAA1 or PRKAA2), preventing phosphorylation by the upstream activating kinase STK11/LKB1.</text>
</comment>
<comment type="domain">
<text evidence="2">The 4 CBS domains mediate binding to nucleotides. Of the 4 potential nucleotide-binding sites, 3 are occupied, designated as sites 1, 3, and 4 based on the CBS modules that provide the acidic residue for coordination with the 2'- and 3'-hydroxyl groups of the ribose of AMP. Of these, site 4 appears to be a structural site that retains a tightly held AMP molecule (AMP 3). The 2 remaining sites, 1 and 3, can bind either AMP, ADP or ATP. Site 1 (AMP, ADP or ATP 1) is the high-affinity binding site and likely accommodates AMP or ADP. Site 3 (AMP, ADP or ATP 2) is the weakest nucleotide-binding site on the gamma subunit, yet it is exquisitely sensitive to changes in nucleotide levels and this allows AMPK to respond rapidly to changes in cellular energy status. Site 3 is likely to be responsible for protection of a conserved threonine in the activation loop of the alpha catalytic subunit through conformational changes induced by binding of AMP or ADP.</text>
</comment>
<comment type="PTM">
<text evidence="7">Phosphorylated by ULK1; leading to negatively regulate AMPK activity and suggesting the existence of a regulatory feedback loop between ULK1 and AMPK.</text>
</comment>
<comment type="polymorphism">
<text evidence="6">PRKAG3 genetic variants can be associated with increased glycogen content in skeletal muscle [MIM:604976]. Muscle fibers from carriers of variant Trp-225 have approximately 90% more muscle glycogen content than controls and decreased levels of intramuscular triglyceride.</text>
</comment>
<comment type="similarity">
<text evidence="9">Belongs to the 5'-AMP-activated protein kinase gamma subunit family.</text>
</comment>
<dbReference type="EMBL" id="AJ249977">
<property type="protein sequence ID" value="CAB65117.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF214519">
<property type="protein sequence ID" value="AAF73987.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC098102">
<property type="protein sequence ID" value="AAH98102.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC098255">
<property type="protein sequence ID" value="AAH98255.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC098277">
<property type="protein sequence ID" value="AAH98277.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC098306">
<property type="protein sequence ID" value="AAH98306.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2424.1">
<molecule id="Q9UGI9-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_059127.2">
<molecule id="Q9UGI9-1"/>
<property type="nucleotide sequence ID" value="NM_017431.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016859832.1">
<molecule id="Q9UGI9-1"/>
<property type="nucleotide sequence ID" value="XM_017004343.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.591634"/>
<dbReference type="ProteinModelPortal" id="Q9UGI9"/>
<dbReference type="SMR" id="Q9UGI9"/>
<dbReference type="BioGrid" id="119791">
<property type="interactions" value="12"/>
</dbReference>
<dbReference type="IntAct" id="Q9UGI9">
<property type="interactions" value="5"/>
</dbReference>
<dbReference type="MINT" id="MINT-8343007"/>
<dbReference type="STRING" id="9606.ENSP00000233944"/>
<dbReference type="ChEMBL" id="CHEMBL3038452"/>
<dbReference type="DrugBank" id="DB00945">
<property type="generic name" value="Acetylsalicylic acid"/>
</dbReference>
<dbReference type="iPTMnet" id="Q9UGI9"/>
<dbReference type="PhosphoSitePlus" id="Q9UGI9"/>
<dbReference type="BioMuta" id="PRKAG3"/>
<dbReference type="DMDM" id="85681287"/>
<dbReference type="EPD" id="Q9UGI9"/>
<dbReference type="PaxDb" id="Q9UGI9"/>
<dbReference type="PeptideAtlas" id="Q9UGI9"/>
<dbReference type="PRIDE" id="Q9UGI9"/>
<dbReference type="Ensembl" id="ENST00000233944">
<molecule id="Q9UGI9-1"/>
<property type="protein sequence ID" value="ENSP00000233944"/>
<property type="gene ID" value="ENSG00000115592"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000439262">
<molecule id="Q9UGI9-1"/>
<property type="protein sequence ID" value="ENSP00000397133"/>
<property type="gene ID" value="ENSG00000115592"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000529249">
<molecule id="Q9UGI9-1"/>
<property type="protein sequence ID" value="ENSP00000436068"/>
<property type="gene ID" value="ENSG00000115592"/>
</dbReference>
<dbReference type="GeneID" id="53632"/>
<dbReference type="KEGG" id="hsa:53632"/>
<dbReference type="UCSC" id="uc002vjb.2">
<molecule id="Q9UGI9-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="53632"/>
<dbReference type="DisGeNET" id="53632"/>
<dbReference type="GeneCards" id="PRKAG3"/>
<dbReference type="HGNC" id="HGNC:9387">
<property type="gene designation" value="PRKAG3"/>
</dbReference>
<dbReference type="MIM" id="604976">
<property type="type" value="gene+phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9UGI9"/>
<dbReference type="OpenTargets" id="ENSG00000115592"/>
<dbReference type="PharmGKB" id="PA33753"/>
<dbReference type="eggNOG" id="KOG1764">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0517">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000009849"/>
<dbReference type="HOGENOM" id="HOG000176880"/>
<dbReference type="HOVERGEN" id="HBG050431"/>
<dbReference type="KO" id="K07200"/>
<dbReference type="OMA" id="AKASRWT"/>
<dbReference type="OrthoDB" id="EOG091G0CZV"/>
<dbReference type="PhylomeDB" id="Q9UGI9"/>
<dbReference type="TreeFam" id="TF313247"/>
<dbReference type="Reactome" id="R-HSA-1445148">
<property type="pathway name" value="Translocation of GLUT4 to the plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1632852">
<property type="pathway name" value="Macroautophagy"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2151209">
<property type="pathway name" value="Activation of PPARGC1A (PGC-1alpha) by phosphorylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-380972">
<property type="pathway name" value="Energy dependent regulation of mTOR by LKB1-AMPK"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5628897">
<property type="pathway name" value="TP53 Regulates Metabolic Genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804756">
<property type="pathway name" value="Regulation of TP53 Activity through Phosphorylation"/>
</dbReference>
<dbReference type="SIGNOR" id="Q9UGI9"/>
<dbReference type="GeneWiki" id="PRKAG3"/>
<dbReference type="GenomeRNAi" id="53632"/>
<dbReference type="PRO" id="PR:Q9UGI9"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000115592"/>
<dbReference type="CleanEx" id="HS_PRKAG3"/>
<dbReference type="ExpressionAtlas" id="Q9UGI9">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9UGI9">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031588">
<property type="term" value="C:nucleotide-activated protein kinase complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004679">
<property type="term" value="F:AMP-activated protein kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007050">
<property type="term" value="P:cell cycle arrest"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006633">
<property type="term" value="P:fatty acid biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0015758">
<property type="term" value="P:glucose transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005978">
<property type="term" value="P:glycogen biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0016236">
<property type="term" value="P:macroautophagy"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1901796">
<property type="term" value="P:regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="InterPro" id="IPR000644">
<property type="entry name" value="CBS_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF00571">
<property type="entry name" value="CBS"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00116">
<property type="entry name" value="CBS"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PROSITE" id="PS51371">
<property type="entry name" value="CBS"/>
<property type="match status" value="4"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0129">CBS domain</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0275">Fatty acid biosynthesis</keyword>
<keyword id="KW-0276">Fatty acid metabolism</keyword>
<keyword id="KW-0444">Lipid biosynthesis</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<feature type="chain" description="5'-AMP-activated protein kinase subunit gamma-3" id="PRO_0000204384">
<location>
<begin position="1"/>
<end position="489"/>
</location>
</feature>
<feature type="domain" description="CBS 1" evidence="3">
<location>
<begin position="197"/>
<end position="258"/>
</location>
</feature>
<feature type="domain" description="CBS 2" evidence="3">
<location>
<begin position="280"/>
<end position="340"/>
</location>
</feature>
<feature type="domain" description="CBS 3" evidence="3">
<location>
<begin position="355"/>
<end position="415"/>
</location>
</feature>
<feature type="domain" description="CBS 4" evidence="3">
<location>
<begin position="427"/>
<end position="486"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="AMP, ADP or ATP 1" evidence="2">
<location>
<begin position="242"/>
<end position="245"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="AMP, ADP or ATP 1" evidence="2">
<location>
<begin position="306"/>
<end position="307"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="AMP 3" evidence="2">
<location>
<begin position="381"/>
<end position="382"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="AMP, ADP or ATP 2" evidence="2">
<location>
<begin position="397"/>
<end position="400"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="AMP, ADP or ATP 2" evidence="2">
<location>
<begin position="453"/>
<end position="454"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="AMP 3" evidence="2">
<location>
<begin position="469"/>
<end position="472"/>
</location>
</feature>
<feature type="short sequence motif" description="AMPK pseudosubstrate">
<location>
<begin position="293"/>
<end position="314"/>
</location>
</feature>
<feature type="binding site" description="AMP, ADP or ATP 2" evidence="2">
<location>
<position position="225"/>
</location>
</feature>
<feature type="binding site" description="AMP, ADP or ATP 1; via amide nitrogen and carbonyl oxygen" evidence="2">
<location>
<position position="285"/>
</location>
</feature>
<feature type="binding site" description="AMP 3" evidence="2">
<location>
<position position="306"/>
</location>
</feature>
<feature type="binding site" description="AMP, ADP or ATP 2" evidence="2">
<location>
<position position="325"/>
</location>
</feature>
<feature type="binding site" description="AMP 3" evidence="2">
<location>
<position position="355"/>
</location>
</feature>
<feature type="binding site" description="AMP 3; via amide nitrogen and carbonyl oxygen" evidence="2">
<location>
<position position="360"/>
</location>
</feature>
<feature type="binding site" description="AMP, ADP or ATP 2" evidence="2">
<location>
<position position="424"/>
</location>
</feature>
<feature type="binding site" description="AMP, ADP or ATP 2; via amide nitrogen and carbonyl oxygen" evidence="2">
<location>
<position position="432"/>
</location>
</feature>
<feature type="binding site" description="AMP 3" evidence="2">
<location>
<position position="453"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_015587" evidence="8">
<location>
<begin position="1"/>
<end position="25"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs692243." id="VAR_023484" evidence="5 6">
<original>P</original>
<variation>A</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs864622003." id="VAR_069470" evidence="6">
<original>E</original>
<variation>Q</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs371222838." id="VAR_069471" evidence="6">
<original>D</original>
<variation>G</variation>
<location>
<position position="103"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs864622004." id="VAR_069472" evidence="6">
<original>G</original>
<variation>V</variation>
<location>
<position position="113"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35050588." id="VAR_048251" evidence="6">
<original>L</original>
<variation>V</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_069473" evidence="6">
<original>L</original>
<variation>P</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs200004875." id="VAR_069474" evidence="6">
<original>G</original>
<variation>S</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs372752820." id="VAR_069475" evidence="6">
<original>G</original>
<variation>S</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs776255177." id="VAR_069476" evidence="6">
<original>M</original>
<variation>T</variation>
<location>
<position position="197"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs776263291." id="VAR_069477" evidence="6">
<original>E</original>
<variation>Q</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs370008874." id="VAR_069478" evidence="6">
<original>R</original>
<variation>Q</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs138130157." id="VAR_069479" evidence="6">
<original>R</original>
<variation>W</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs41272689." id="VAR_069480" evidence="6">
<original>Q</original>
<variation>R</variation>
<location>
<position position="260"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs367916025." id="VAR_069481" evidence="6">
<original>I</original>
<variation>T</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs864622005." id="VAR_069482" evidence="6">
<original>R</original>
<variation>C</variation>
<location>
<position position="307"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs551272603." id="VAR_069483" evidence="6">
<original>R</original>
<variation>Q</variation>
<location>
<position position="340"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs33985460." id="VAR_048252" evidence="6">
<original>R</original>
<variation>W</variation>
<location>
<position position="340"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs200750014." id="VAR_069484" evidence="6">
<original>R</original>
<variation>M</variation>
<location>
<position position="446"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34720726." id="VAR_069485" evidence="6">
<original>A</original>
<variation>V</variation>
<location>
<position position="482"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs149508864." id="VAR_069486" evidence="6">
<original>D</original>
<variation>N</variation>
<location>
<position position="485"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAF73987." ref="2" evidence="9">
<original>A</original>
<variation>T</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAB65117." ref="1" evidence="9">
<original>MQ</original>
<variation>IE</variation>
<location>
<begin position="188"/>
<end position="189"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAB65117." ref="1" evidence="9">
<original>Q</original>
<variation>K</variation>
<location>
<position position="423"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAB65117." ref="1" evidence="9">
<original>ALGA</original>
<variation>PSGPEKI</variation>
<location>
<begin position="486"/>
<end position="489"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P80385"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00703"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14722619"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17878938"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21460634"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10818001"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000305"/>
<sequence length="489" mass="54258" checksum="0E93E2B5117B328D" modified="2005-09-13" version="3">
MEPGLEHALRRTPSWSSLGGSEHQEMSFLEQENSSSWPSPAVTSSSERIRGKRRAKALRW
TRQKSVEEGEPPGQGEGPRSRPAAESTGLEATFPKTTPLAQADPAGVGTPPTGWDCLPSD
CTASAAGSSTDDVELATEFPATEAWECELEGLLEERPALCLSPQAPFPKLGWDDELRKPG
AQIYMRFMQEHTCYDAMATSSKLVIFDTMLEIKKAFFALVANGVRAAPLWDSKKQSFVGM
LTITDFILVLHRYYRSPLVQIYEIEQHKIETWREIYLQGCFKPLVSISPNDSLFEAVYTL
IKNRIHRLPVLDPVSGNVLHILTHKRLLKFLHIFGSLLPRPSFLYRTIQDLGIGTFRDLA
VVLETAPILTALDIFVDRRVSALPVVNECGQVVGLYSRFDVIHLAAQQTYNHLDMSVGEA
LRQRTLCLEGVLSCQPHESLGEVIDRIAREQVHRLVLVDETQHLLGVVSLSDILQALVLS
PAGIDALGA
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>